AlzeCure Pharma AB (publ) (OM: ALZCUR)
Health Care · Pharmaceuticals · SE
Skr6.80
+0.59% today · +171.5% 1Y
AlzeCure Pharma AB (publ) (OM: ALZCUR) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $93.23M and employs 10 people.
Over the last twelve months the share price has gained 171.5%, trading between 1.30 and 8.68.
Tweenvest scores AlzeCure Pharma AB (publ) across four factors: quality 53/100, value 54/100. Its strongest factor is value.
ALZCUR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $93.23M
- Revenue (TTM)
- $10.04M
- P/E
- 25.04
- EPS
- 0.27
- Dividend yield
- —
- Beta (5Y)
- -0.11
- 52-week high
- Skr8.68
- 52-week low
- Skr1.30
- Avg volume (3M)
- —
- Shares outstanding
- 137.90M
- Employees
- 10
- Next earnings
- —
About AlzeCure Pharma AB (publ)
AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are in preclinical trial for the treatment of Alzheimer’s disease; ACD440, a TRPV1 antagonist that has completed phase I clinical trial for neuropathic pain indications; and ACD137, negative allosteric modulator (NAM) of TrkA receptors for osteoarthritic pain indications. The company was founded in 2012 and is based in Huddinge, Sweden.
- ISIN
- SE0010133785
- Founded
- 2012
- Listed since
- Nov 28, 2018
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Pak Fah Yeow International LimitedSEHK: 239 | $94.91M | HK$2.39 | -2.45% |
| Merdury Biopharmaceutical CorporationTPEX: 6932 | $94.16M | NT$7.04 | +15.22% |
| Unité de Fabrication des Médicaments S.ABVMT: UMED | $93.89M | DT8.77 | -0.34% |
| PT Merck TbkIDX: MERK | $93.89M | Rp3,750.00 | -1.06% |
| Rani Therapeutics Holdings, Inc.NasdaqGM: RANI | $92.22M | $0.80 | +0.88% |
| Stella Pharma CorporationTSE: 4888 | $92.15M | ¥394.00 | -7.51% |
| Shree Ganesh Remedies LimitedBSE: 540737 | $90.37M | Rs681.25 | -1.72% |
| Renascience Inc.TSE: 4889 | $89.79M | ¥1,032.00 | -6.44% |
Figures last refreshed Oct 11, 2026.